Blood Coagulation, Fibrinolysis and Cellular Haemostasis
Schattauer GmbH
Anticoagulation in ambulatory cancer patients with no indication for prophylactic or therapeutic anticoagulation
A cost-effectiveness analysis from a U.S. perspective
Allyson M. Pishko
1
Department of Medicine, Division Hematology/Oncology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
,
Kenneth J. Smith
2
Section of Decision Sciences and Clinical Systems Modeling, Division Internal Medicine and Center for Research on Health Care Data Center, Pittsburgh, Pennsylvania, USA
,
Margaret V. Ragni
1
Department of Medicine, Division Hematology/Oncology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
3
Hemophilia Center of Western PA, Pittsburgh, Pennsylvania, USA